Edesa Biotech (EDSA) Tops Q1 EPS by 67c

Edesa Biotech (NASDAQ: EDSA) reported Q1 EPS of ($0.54), $0.67 better than the analyst estimate of ($1.21).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral